(Q74311536)
Statements
The renal and systemic hemodynamic effects of a nitric oxide-synthase inhibitor are reversed by a selective endothelin(a) receptor antagonist in men (English)
A Schmidt
M Bayerle-Eder
H Pleiner
C Zeisner
M Wolzt